Robert F. Kennedy Jr. (HHS Secretary, 2025-)

Appointed HHS Secretary by Trump 2025. Long-running critic of regulatory capture + vaccine-safety protocols. **June 2025:** terminated all 17 sitting members of CDC's Advisory Committee on Immunization Practices (ACIP) in single day; declared 'rubber stamp for industry profit-taking agendas' + replaced with Robert Malone, Martin Kulldorff, Retsef Levi, Cody Meissner. New ACIP downgraded broad COVID-19 vaccination recommendations + voted to stop recommending most newborn Hepatitis B shots. **March 2025 DOGE HHS purge:** terminated 10,000 full-time HHS employees (82K → 62K). 28 divisions consolidated into 15. Refocused agency toward chronic illness + clean water + environmental toxins under new Administration for a Healthy America (AHA). Documented institutional-shatter operator. **Report #84 (May 7 2026 MV Hondius audit):** the Joint Statement by Secretary of State Marco Rubio + RFK Jr. (HHS) on January 24 2026 - terminating US membership in the WHO - was empirically tested by the MV Hondius hantavirus cluster (April-May 2026). RFK's bilateral-substitution architecture is operational: CDC monitored residents in 5 states (GA/CA/AZ/TX/VA) through direct intelligence sharing with European and African counterparts during the cluster, conspicuously omitting the WHO. Confirms H2 - genuinely new operational architecture (direct intelligence sharing replacing multilateral apparatus), not costume. Report #90 H4 max load-bearing: As HHS Secretary, RFK Jr. instrumentally executed President Trump's April 18, 2026 Psychedelic Executive Order. Directed FDA and DEA to clear federal roadblocks for Schedule I compounds and establish 'Right to Try' pathways for ibogaine, psilocybin, MDMA, methylone. EO mandates ≥$50M via ARPA-H for ibogaine research + state-level psychedelic programs. FDA Commissioner Marty Makary subsequently issued Commissioner's National Priority Vouchers to corporate operators in psilocybin/methylone study. RFK Jr.'s March 16 2024 American Wellness Summit appearance in Austin alongside Aubrey Marcus + Calley Means established the pre-state-power memetic + cadre architecture that culminated in the April 18 2026 EO. Cross-substrate backfill (Reports #88 + #90 share MAHA-administrative architecture): RFK Jr's HHS Secretary role is the operational interface for two parallel biological-substrate policy events — (1) Report #88 Cloning Substrate (FDA Plausible Mechanism Framework Feb 23 2026 + NIH NOT-OD-26-031 Jan 23 2026 + post-Dolly 30-year SCNT/iPSC architecture + He Jiankui regulatory-bypass + Colossal Biosciences in-Q-Tel capital stack); (2) Report #90 Psychedelic Executive Order (April 18 2026 + $50M ARPA-H ibogaine + FDA Right-to-Try Schedule I expansion + Commissioner's National Priority Vouchers). Both events are state-level biological-substrate regulatory-bypass deployments under the same Secretary, executed within 90 days. The MAHA-administrative architecture treats cloning-pharmaceutical AND psychedelic-pharmaceutical capital deployment as a single operationalized arc. [Live pass Jul 27 2026] FDA compounding advisory panel voted (Jul 23-24) to add 6 of 7 peptides (BPC-157, KPV, TB-500, MOTS-c, epitalon, semax) to the 503A list against FDA scientists' own safety warnings, with conflict-of-interest ties flagged — the MAHA regulatory-bypass agenda.